Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Proctor

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Antimicrobial Agents|March 18, 2000
Staphylococcus aureus small colony variants, electron transport and persistent infectionsP J McNamara, R A Proctor
Microbial Pathogenesis|June 1, 1988
Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysinJ M Vann, R A Proctor
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 31, 2014
Where does a Staphylococcus aureus vaccine stand?V G Fowler, R A Proctor
Antimicrobial Agents and Chemotherapy|November 1, 1985
Cilastatin does not alter superoxide dismutase activityR A Proctor, J A Textor
Critical Care Medicine|July 13, 2000
Potential risk factors for developing apoptosis during septic shockL C Denlinger, R A Proctor
Analytical Biochemistry|February 1, 1984
Effect of chelating agents and superoxide on human neutrophil NAD(P)H oxidationM B Goetz, R A Proctor
Annals of Internal Medicine|December 15, 1995
Normalization of intracellular calcium: a sweet solution to neutrophil dysfunction in diabetes?M B Goetz, R A Proctor
Science (New York, N.Y.)|August 22, 1980
Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureusD F Mosher, R A Proctor
Critical Care Medicine|March 22, 2001
Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemiaL C Denlinger, R A Proctor
Infection and Immunity|August 1, 1985
Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid AR A Proctor, J A Textor
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Antimicrobial Agents|March 18, 2000
Staphylococcus aureus small colony variants, electron transport and persistent infectionsP J McNamara, R A Proctor
Microbial Pathogenesis|June 1, 1988
Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysinJ M Vann, R A Proctor
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 31, 2014
Where does a Staphylococcus aureus vaccine stand?V G Fowler, R A Proctor
Antimicrobial Agents and Chemotherapy|November 1, 1985
Cilastatin does not alter superoxide dismutase activityR A Proctor, J A Textor
Critical Care Medicine|July 13, 2000
Potential risk factors for developing apoptosis during septic shockL C Denlinger, R A Proctor
Analytical Biochemistry|February 1, 1984
Effect of chelating agents and superoxide on human neutrophil NAD(P)H oxidationM B Goetz, R A Proctor
Annals of Internal Medicine|December 15, 1995
Normalization of intracellular calcium: a sweet solution to neutrophil dysfunction in diabetes?M B Goetz, R A Proctor
Science (New York, N.Y.)|August 22, 1980
Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureusD F Mosher, R A Proctor
Critical Care Medicine|March 22, 2001
Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemiaL C Denlinger, R A Proctor
Infection and Immunity|August 1, 1985
Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid AR A Proctor, J A Textor
Pageof 11